RMG Wealth Management’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

RMG Wealth Management’s Portfolio KLDO Stock Details KLDO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$0	Hold	70	–	–	﹤0.01%	749
2026 Q1	$0	Buy	+70	New	–	﹤0.01%	664
2025 Q4	–	Sell	-70	Closed	–	–	516
2025 Q3	$0	Hold	70	–	–	﹤0.01%	360
2025 Q2	$0	Buy	+70	New	–	﹤0.01%	326

RMG Wealth Management's KLDO Position: Q2 2026 in Review

RMG Wealth Management held its Kaleido Biosciences, Inc. Common Stock (KLDO) position steady in Q2 2026 at 70 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #749.

RMG Wealth Management first reported a position in KLDO in Q2 2025 and has held it in 4 quarters since. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2026.

RMG Wealth Management held 70 shares of Kaleido Biosciences, Inc. Common Stock worth $0 as of Q2 2026.
RMG Wealth Management left its Kaleido Biosciences, Inc. Common Stock share count unchanged in Q2 2026.
Kaleido Biosciences, Inc. Common Stock made up ﹤0.01% of RMG Wealth Management's portfolio in Q2 2026, its #749 holding.
RMG Wealth Management first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2025 and has held it in 4 quarters since.
3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2026.

Based on RMG Wealth Management's 13F filing for Q2 2026, filed 13 Aug 2026.